Celsius (NASDAQ:CELH) Price Target Raised to $75.00

Celsius (NASDAQ:CELH) had its price target increased by Needham & Company LLC from $70.00 to $75.00 in a research report released on Friday,Benzinga reports. The brokerage currently has a buy rating on the stock.

Several other research firms have also commented on CELH. KeyCorp started coverage on Celsius in a report on Tuesday, December 16th. They set a “sector weight” rating on the stock. Citigroup cut their price objective on shares of Celsius from $73.00 to $65.00 and set a “buy” rating for the company in a research report on Friday, November 7th. Piper Sandler reiterated an “overweight” rating and issued a $65.00 target price (up from $61.00) on shares of Celsius in a report on Thursday, January 29th. UBS Group reissued a “buy” rating and issued a $70.00 price target (up from $65.00) on shares of Celsius in a research note on Wednesday, January 14th. Finally, Roth Mkm reaffirmed a “buy” rating on shares of Celsius in a research report on Monday, February 9th. Nineteen analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Celsius currently has an average rating of “Moderate Buy” and an average target price of $67.72.

Celsius Trading Down 0.9%

CELH opened at $53.61 on Friday. The firm has a market capitalization of $13.82 billion, a price-to-earnings ratio of 214.44, a price-to-earnings-growth ratio of 0.85 and a beta of 0.89. The company’s 50 day simple moving average is $49.66 and its two-hundred day simple moving average is $52.07. Celsius has a 1-year low of $24.04 and a 1-year high of $66.74. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.68 and a quick ratio of 1.37.

Celsius (NASDAQ:CELH) last posted its quarterly earnings results on Thursday, February 26th. The company reported $0.26 EPS for the quarter, beating the consensus estimate of $0.19 by $0.07. The firm had revenue of $721.63 million during the quarter, compared to analysts’ expectations of $638.17 million. Celsius had a return on equity of 37.68% and a net margin of 4.29%.The business’s revenue for the quarter was up 117.2% on a year-over-year basis. During the same quarter last year, the firm earned ($0.11) earnings per share. Analysts expect that Celsius will post 0.89 EPS for the current fiscal year.

Institutional Trading of Celsius

Several institutional investors have recently added to or reduced their stakes in the stock. Spire Wealth Management boosted its position in shares of Celsius by 7.6% during the third quarter. Spire Wealth Management now owns 2,547 shares of the company’s stock worth $146,000 after buying an additional 180 shares during the period. KLP Kapitalforvaltning AS lifted its stake in Celsius by 0.6% during the 3rd quarter. KLP Kapitalforvaltning AS now owns 33,100 shares of the company’s stock worth $1,903,000 after acquiring an additional 200 shares in the last quarter. EverSource Wealth Advisors LLC boosted its holdings in Celsius by 16.1% during the 4th quarter. EverSource Wealth Advisors LLC now owns 1,501 shares of the company’s stock valued at $69,000 after acquiring an additional 208 shares during the period. TriaGen Wealth Management LLC grew its position in Celsius by 1.4% in the 3rd quarter. TriaGen Wealth Management LLC now owns 15,824 shares of the company’s stock valued at $910,000 after acquiring an additional 218 shares in the last quarter. Finally, Whittier Trust Co. of Nevada Inc. increased its stake in Celsius by 27.8% during the fourth quarter. Whittier Trust Co. of Nevada Inc. now owns 1,091 shares of the company’s stock worth $53,000 after purchasing an additional 237 shares during the period. Institutional investors and hedge funds own 60.95% of the company’s stock.

Key Stories Impacting Celsius

Here are the key news stories impacting Celsius this week:

• Positive Sentiment: Q4 beat and outsized revenue growth — Celsius reported Q4 revenue of ~$721.6M (+117% YoY) and non‑GAAP EPS $0.26, both well above consensus; full‑year revenue topped $2.5B. The results drove strong intraday gains after the release. Read More.
• Positive Sentiment: Analyst upgrades and higher price targets — Bank of America upgraded CELH to Buy (PT $65) and Needham raised its target to $75, both citing the strong quarter and momentum from recent brand acquisitions; those calls imply meaningful upside from current levels. Read More. Read More.
• Neutral Sentiment: Strategic update and medium‑term margin target — Management reiterated a multi‑brand strategy (Celsius, Alani Nu, Rockstar) and plans to bring gross margins back to the low‑50% range by end‑2026 as integration and innovation progress; this is constructive but depends on execution. Read More.
• Neutral Sentiment: Short‑interest reporting appears unreliable — a February short‑interest entry shows zero shares / NaN change, indicating a data anomaly rather than a meaningful change in short positioning; treat reported short‑interest figures with caution.
• Negative Sentiment: Near‑term margin pressure and integration costs — several writeups note that while scale and revenue are rising, integration expenses and margin compression are present this year, which could weigh on near‑term profitability and investor sentiment. Read More.

Celsius Company Profile

Celsius Holdings, Inc is an American beverage company known for its line of fitness and energy drinks formulated to support active lifestyles. The company’s flagship product, the Celsius® brand, features beverages enhanced with ingredients such as green tea extract, guarana seed extract and essential vitamins, positioned as a functional alternative to traditional energy drinks. These products are designed to deliver a blend of ingredients that support metabolism and sustained energy without high sugar content or artificial preservatives.

In addition to its core carbonated drink portfolio, Celsius has expanded its offerings to include powder mixes and non-carbonated ready-to-drink variants, catering to consumer preferences around taste, convenience and nutritional needs.